Login / Signup

The effects of adding angiotensin receptor neprilysin inhibitors to usual care in patients with heart failure: a protocol for a systematic review of randomised clinical trials with meta-analysis and trial sequential analysis.

Emil Eik NielsenJoshua FeinbergIlan RaymondMichael Hecht OlsenFrank Victor Steensgaard-HansenJanus Christian Jakobsen
Published in: Systematic reviews (2019)
PROSPERO CRD42019129336.
Keyphrases
  • clinical trial
  • systematic review
  • phase ii
  • study protocol
  • phase iii
  • open label
  • healthcare
  • randomized controlled trial
  • double blind
  • palliative care
  • meta analyses
  • angiotensin ii
  • quality improvement